From Biomarkers to Clinical Trials: A Decade Long Partnership Funds Innovative Research to Combat Ocular Melanoma
Just over ten years ago, the AACR and the Ocular Melanoma Foundation (OMF) began a partnership dedicated to funding research to find a cure for ocular melanoma. Although a rare disease, uveal melanoma is the most common ocular cancer in adults with a poor long-term prognosis. The ten-year history of the AACR-OMF Grants Program is a clear example of the power of partnership in combating cancer.